(Q84290611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

1 reference

corrigendum / erratum

Erratum to: The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer

0 references

author

Philip S. Low

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Joost Bart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Lucia M A Crane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Henriette J G Arts

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Marleen van Oosten

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Ate G J van der Zee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gooitzen M van Dam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

7 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

9-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13402-011-0052-6

3 February 2020

exact match

0 references

cites work

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

1 reference

12 December 2020

Farletuzumab in epithelial ovarian carcinoma

1 reference

12 December 2020

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

1 reference

12 December 2020

A step further in understanding the biology of the folate receptor in ovarian carcinoma.

1 reference

12 December 2020

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results

1 reference

12 December 2020

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

1 reference

12 December 2020

1 reference

12 December 2020

Overexpression of folate binding protein in ovarian cancers.

1 reference

12 December 2020

Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical

1 reference

12 December 2020

Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix

1 reference

12 December 2020

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

1 reference

12 December 2020

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

1 reference

12 December 2020

Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha

1 reference

12 December 2020

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

1 reference

12 December 2020

Folate receptor alpha as a tumor target in epithelial ovarian cancer

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue.

1 reference

12 December 2020

10.1007/S13402-011-0052-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647742%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

PubMed publication ID

21647742

1 reference